Fever without localizing signs in children: A review in the post-Hib and postpneumococcal era

Minerva Pediatrica

Volumn 61, Issue 5, 2009, Pages 489-501

  Chancey, R J ^a   Jhaveri, R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacterial infections; Haemophilus influenzae type b; Streptococcus pneumonia; Vaccines

Indexed keywords

AMPICILLIN; C REACTIVE PROTEIN; CEFAZOLIN; CEFOXITIN; CEFTRIAXONE; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIURIA; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILD; ENTEROVIRUS; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INTRAPARTUM CARE; KLEBSIELLA; LEUKOCYTE COUNT; NEISSERIA MENINGITIDIS; NEWBORN; NEWBORN SEPSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VESICOURETERAL REFLUX;

AGE FACTORS; ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; BACTERIAL VACCINES; CHILD; FEMALE; FEVER; HAEMOPHILUS INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL INFECTIONS; PRACTICE GUIDELINES AS TOPIC; RISK; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 75149137791     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Jr., Powell KR et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993;22:1198-210.
2. Shapiro ED, Aaron NH, Wald ER, Chiponis D. Risk factors for development of bacterial meningitis among children with occult bacteremia. J Pediatr 1986;109:159.
3. Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr 1985;107:855-60.
4. McGowan JE, Jr, Bratton L, Klein JO, Finland M. Bacteremia in febrile children seen in a "walk-in" pediatric clinic. N Engl J Med 1973;288:1309-12.
5. Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1995". MMWR Morb Mortal Wkly Rep 1996;45:901-6.
6. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis 1990;162:1316-23.
7. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997;337:970-6.
8. McCarthy PL, Dolan TF. The serious implications of high fever in infants during their first three months. Six years' experience at Yale-New Haven Hospital Emergency Room. Clin Pediatr (Phila) 1976;15:794-6.
9. Crain EF, Shelov SP. Febrile infants: predictors of bacteremia. J Pediatr 1982;101:686-9.
10. Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants. Pediatrics 1990;85:1040-3.
11. McCarthy PL, Sharpe MR, Spiesel SZ, Dolan TF, Forsyth BW, DeWitt TG et al. Observation scales to identify serious illness in febrile children. Pediatrics 1982;70:802-9.
12. Marshall R, Teele DW, Klein JO. Unsuspected bacteremia due to Haemophilus influenzae: outcome in children not initially admitted to hospital. J Pediatr 1979;95(5 Pt 1):690-5.
13. North AF, Jr. Bacteriuria in children with acute febrile illnesses. J Pediatr 1963;63:408-11.
14. Shah KJ, Robins DG, White RH. Renal scarring and vesicoureteric reflux. Arch Dis Child 1978;53:210-7.
15. Lin DS, Huang SH, Lin CC, Tung YC, Huang TT, Chiu NC et al. Urinary tract infection in febrile infants younger than eight weeks of age. Pediatrics 2000;105:E20.
16. Byington CL, Enriquez FR, Hoff C, Tuohy R, Taggart EW, Hillyard DR et al. "Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections". Pediatrics 2004;113:1662-6.
17. Roberts KB, Charney E, Sweren RJ, Ahonkhai VI, Bergman DA, Coulter MP et al. Urinary tract infection in infants with unexplained fever: a collaborative study. J Pediatr 1983;103:864-7.
18. Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993;123:17-23.
19. Crain EF, Gershel JC. Urinary tract infections in febrile infants younger than 8 weeks of age. Pediatrics 1990;86:363-7.
20. Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992;120:22-7.
21. Baraff LJ, Oslund SA, Schriger DL, Stephen ML. Probability of bacterial infections in febrile infants less than three months of age: a meta-analysis. Pediatr Infect Dis J 1992;11:257-64.
22. Trends in perinatal group B streptococcal disease - United States, 2000-2006". MMWR Morb Mortal Wkly Rep 2009;58:109-12.
23. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
24. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973;82:724-9.
25. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-18.
26. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al. "Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis". N Engl J Med 2000;342:15-20.
27. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
28. Perinatal group B streptococcal disease after universal screening recommendations - United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2007;56:701-5.
29. Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics 2003; 111(5 Pt 1):964-8.
30. Benito-Fernandez J, Vazquez-Ronco MA, Morteruel-Aizkuren E, Mintegui-Raso S, Sanchez-Etxaniz J, Fernandez-Landaluce A. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J 2006;25:1153-7.
31. Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 1999;18:258-61.
32. Krief WI, Levine DA, Platt SL, Macias CG, Dayan PS, Zorc JJ et al. Influenza virus infection and the risk of serious bacterial infections in young febrile infants. Pediatrics 2009;124:30-9.
33. Bilavsky E, Shouval DS, Yarden-Bilavsky H, Fisch N, Ashkenazi S, Amir J. A prospective study of the risk for serious bacterial infections in hospitalized febrile infants with or without bronchiolitis. Pediatr Infect Dis J 2008;27:269-70.
34. Levine DA, Platt SL, Dayan PS, Macias CG, Zorc JJ, Krief W et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics 2004;113:1728-34.
35. Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992;340:592-4.
36. From the Centers for Disease Control and Prevention. Progress toward eliminating Haemophilus influenzae type b disease among infants and children - United States, 1987-1997. JAMA 1999;281:409-10.
37. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. Pediatrics 2000;106:505-11.
38. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998;152: 624-8.
39. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-95.
40. Kaplan SL, Mason EO, Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004;113(3 Pt 1):443-9.
41. Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB et al. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 2006;25:293-300.
42. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease - United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005;54:893-7.
43. Lin PL, Michaels MG, Janosky J, Ortenzo M, Wald ER, Mason EO, Jr. Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine. Pediatrics 2003;111:896-9.
44. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007;196:1346-54.
45. Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005". MMWR Morb Mortal Wkly Rep 2008;57:144-8.
46. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J et al. "Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine". Pediatr Infect Dis J 2007;26:468-72.
47. Carstairs KL, Tanen DA, Johnson AS, Kailes SB, Riffenburgh RH. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. Ann Emerg Med 2007;49:772-7.
48. Sard B, Bailey MC, Vinci R. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Pediatr Emerg Care 2006;22:295-3004.
49. Waddle E, Jhaveri R. Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine. Arch Dis Child 2009;94:144-7.
50. Rudinsky SL, Carstairs KL, Reardon JM, Simon LV, Riffenburgh RH, Tanen DA. Serious bacterial infections in febrile infants in the post-pneumococcal conjugate vaccine era. Acad Emerg Med 2009;16:585-90.
51. Wilkinson M, Bulloch B, Smith M. Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. Acad Emerg Med 2009;16:220-5.
52. Waddle EA, Hanson KE, Jhaveri R. Follow-up analysis of serious bacterial infections in children with fever without localising signs: how do the National Institute for Clinical Excellence guidelines perform with the emergence of non-vaccine pneumococcal serotypes?. Arch Dis Child 2009;94:247.
53. American College of Emergency Physicians Clinical Policies Committee; American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever". Ann Emerg Med 2003;42:530-45.
54. Baraff LJ. Editorial: Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 2003;42:546-9.
55. National Institute for Health and Clinical Excellence (UK). Feverish illness in children: assessment and initial management in children younger than 5 years; 2007:1-18.